Cyclophosphamide trials for Systemic Lupus Erythematosus

All Cyclophosphamide trials · All Systemic Lupus Erythematosus trials

Phase breakdown

Recruiting trials studying Cyclophosphamide for Systemic Lupus Erythematosus

• Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
  NCT06581562 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
  NCT06434363 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• US Zamto-cel Autoimmune Diseases
  NCT06708845 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Cyclophosphamide for Systemic Lupus Erythematosus?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.